Celyad SA (CYAD) Reports Activation of Second Site in Belgium for THINK Trial
Tweet Send to a Friend
Celyad (NASDAQ: CYAD), a leader in the discovery and development of engineered cell-based therapies, today announced the activation of a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
